scispace - formally typeset
O

Otto C. Boerman

Researcher at Radboud University Nijmegen

Publications -  358
Citations -  17532

Otto C. Boerman is an academic researcher from Radboud University Nijmegen. The author has contributed to research in topics: Radioimmunotherapy & In vivo. The author has an hindex of 66, co-authored 355 publications receiving 15882 citations. Previous affiliations of Otto C. Boerman include Radboud University Nijmegen Medical Centre.

Papers
More filters
Journal ArticleDOI

In vivo molecular prediction of carbonic anhydrase IX-G250MN expression on immunotherapy outcome in renal cancer

TL;DR: To the Editor: It is with great interest that the article of Atkins et al. about the possible usefulness of carbonic anhydrase IX-G250MN (CAIX) expression as a biomarker to predict responses to interleukin-2 therapy in renal is read.
Proceedings ArticleDOI

Abstract 2761: Temsirolimus is effective as a single agent and in combination with cisplatin or bevacizumab in preclinical osteosarcoma models.

TL;DR: Temsirolimus is effective as a single agent in OS-1 and OS-33 osteosarcoma models, but the combination with cisplatin or bevacizumab induced a superior anti-tumor response compared to all monotherapies.
Journal ArticleDOI

Radiolabeled Imaging Probes Targeting Angiogenesis for Personalized Medicine

TL;DR: This review focuses on the development of radiolabeled probes to image four key proteins expressed during angiogenesis, namely vascular endothelial growth factor and its receptor, integrin αv β3, the extracellular domain of fibronectin and matrix metalloproteases, and how these probes can be utilized for personalized anti-angiogenic therapy.